Angelina Marr

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

R. Loch Macdonald, Randall T. Higashida, E. Keller et al. · The Lancet Neurology · 2011 · 638 citations

Medicine, Neurosurgery, Surgery +14

Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis

Dinesh Khanna, Christopher P. Denton, Peter A. Merkel et al. · JAMA · 2016 · 131 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Randomised Trial of Clazosentan, an Endothelin Receptor Antagonist, in Patients with Aneurysmal Subarachnoid Hemorrhage Undergoing Surgical Clipping (CONSCIOUS-2)

R. Loch Macdonald, Randall T. Higashida, E. Keller et al. · Acta neurochirurgica. Supplementum · 2012 · 72 citations

Medicine, Neurosurgery, Surgery +12

Preventing Vasospasm Improves Outcome After Aneurysmal Subarachnoid Hemorrhage: Rationale and Design of CONSCIOUS-2 and CONSCIOUS-3 Trials

R. Loch Macdonald, Randall T. Higashida, E. Keller et al. · Neurocritical Care · 2010 · 64 citations

Medicine, Neurological Surgery, Neurosurgery +16

Cancer survival among adolescents in France

Emmanuel Désandes, Brigitte Lacour, Danièle Sommelet et al. · European Journal of Cancer · 2006 · 32 citations

Medicine, Oncology, Pediatrics +9